Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04732754
Other study ID # UP 5839.20
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date September 1, 2021
Est. completion date December 10, 2022

Study information

Verified date August 2021
Source Instituto de Cardiologia do Rio Grande do Sul
Contact Tainah Ortiz, M.Sc
Phone 55 51 999171990
Email tainahortiz05@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study evaluates the cocoa supplementation and aerobic exercise on central pressure and arterial stiffness parameters in physically inactive middle-aged individuals. 500mg capsules will be offered to all patients. Of these, half will offer the content of 500mg of cocoa per capsule or placebo capsules. The placebo will contain a pharmacologically inert substance (microcrystalline cellulose) of the same color. A half will start 50' aerobic training 3 times/week while the other half will continue without exercise.


Description:

Cardiovascular diseases (CVDs) are the number one cause of death in the world: more people die annually from CVDs than from any other cause. The arterial hypertension is one of the main predictors of CVDs. The number of adults with high blood pressure increased from 594 million in 1975 to 1.13 billion in 2015( WHO, 2020). Due to the great increase in Hypertension around the world, new technological ways of assessing pressure have been discussed in the clinical setting, not only peripheral, but also central. In this sense, the applanation tonometry of different arteries (carotid and radial), the analysis of pulses by various algorithms and the ability to estimate the shape of the pulse wave in the descending aorta root has been gaining prominence. Flavonoids are a group of polyphenol compounds found in plants. The possible benefits from these compounds are related to cardiovascular health through specific actions on the artery wall. Prospective studies have shown that flavonoids can improve arterial stiffness, measured by Pulse Wave Velocity (PWV). Physical exercise can intensifies organic functioning in different systems oh human body, including the cardiovascular. Studies has shown that chronic adaptations of pshysical exercise can improve arterial stiffness and central blood pressure parameters.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 84
Est. completion date December 10, 2022
Est. primary completion date September 1, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 30 Years to 50 Years
Eligibility Inclusion Criteria: - Sedentary lifestyle (IPAQ- International Physical Activity Questionnaire); - Eutrophic or overweight (BMI >18,5kg/m² and <30kg/m²). Exclusion Criteria: - Individuals with a feverish state and / or infectious disease; - Individuals with diabetes mellitus or coronary artery disease; - Individuals who have any recent cardiovascular events (last 3 months) or chronic renal failure; history of malignant diseases with life expectancy <2 years; - Use of statins; - Smokers (those who have never smoked or smoked less than 100 cigarettes (5 bags of 20 cigarettes) in their lifetime and for at least 5 years); - Alcoholics (The WHO estabilish ad acceptable the consumption is up to 15 doses / week for men and 10 for women, with 1 dose equivalent to approximately 350 mL of beer, 150 mL of wine or 40 mL of a distilled drink, considering that each contains between 10 and 15 g of ethanol);

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Aerobic exercise + Theobroma cocoa (AETC)
Daily consumption of 500mg cocoa in capsules and 3 sessions of physical exercise / week, 50 min / session, with moderate intensity of 50-70% of VO2peak for 8 weeks.
Control Group (CG)
Daily consumption of placebo capsules for 8 weeks
Aerobic Exercise (AE)
Daily consumption of placebo capsules and 3 sessions of physical exercise / week, 50 min / session, with moderate intensity of 50-70% of VO2peak for 8 weeks.
Theobroma Cocoa (TC)
Daily consumption of 500mg cocoa in capsules for 8 weeks.

Locations

Country Name City State
Brazil Instituto de Cardiologia do Rio Grande do Sul/Fundação Universitária de Cardiologia Porto Alegre Rio Grande Do Sul

Sponsors (1)

Lead Sponsor Collaborator
Instituto de Cardiologia do Rio Grande do Sul

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Arterial Stiffness by Pulse Wave Velocity The assessment of arterial stiffness will be carried out using the non-invasive method of PWV , which is obtained by dividing the carotid-femoral distance by the systolic wave travel time (in the unit of m / s) It will be checked by the Complior Analyzer equipment, with the volunteer in a supine position in an air-conditioned environment and controlled lighting in a LIC room, with the sensors placed over the right carotid and femoral arteries. The distance between the two points is measured by an infantometer and the data of pressure, total body weight and distance between the points of the sensors in the carotid artery and in the femoral artery are entered in the software to calculate the PWV. This analysis will be carried out before and after the intervention period. 8 weeks
See also
  Status Clinical Trial Phase
Completed NCT04053686 - An Intervention to Reduce Prolonged Sitting in Police Staff N/A
Recruiting NCT04994340 - Physical Activity Observatory of Castilla-La Mancha
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT05019482 - Intervention Program Among University Student to Promote Physical Activity and Reduce the Sedentary Time N/A
Not yet recruiting NCT05963893 - Promoting a Healthy Life Through Gender Equity
Completed NCT05059964 - Circuit Training and Aerobic Exercise Among Sedentary Elderly Population N/A
Completed NCT06063187 - Technology-based Fall Risk Assessments for Older Adults in Low-income Settings
Completed NCT04042610 - Office Worker Behavior and Health Study N/A
Recruiting NCT05961943 - RESPONSE-2-PAD to Reduce Sedentary Time in Peripheral Arterial Disease Patients N/A
Completed NCT05013021 - Sprint Interval Training on the Endurance, Strength and Velocity Capacities of Healthy Sedentary Subjects N/A
Active, not recruiting NCT04569578 - Increasing Children's Physical Activity by Policy (CAP) N/A
Recruiting NCT04195165 - The Effect of Sitting and Moderate Exercise on Plasma Insulin and Glucose Responses to an Oral Glucose Tolerance Test N/A
Completed NCT04082624 - Workplace Wellness: Improving Your Experience at Work N/A
Completed NCT02544867 - Optimizing Sedentary Behavior Interventions to Affect Acute Physiological Changes N/A
Recruiting NCT06024434 - Effects of Specialized Strength Training Protocol On Functional Movement Status of Office Workers N/A
Withdrawn NCT05605028 - A Mental Health Intervention for a Community Program Called the PowerObesity N/A
Completed NCT04556695 - Exploration of Sedentary Behaviour Among General Practitioners: A Mixed Methods Study
Recruiting NCT05790837 - Workplace Intervention to Reduce Sitting Time: a Randomized Clinical Trial. N/A
Enrolling by invitation NCT06018974 - Digital Gaming Intervention for Older People in Long-term Care N/A
Recruiting NCT05534256 - Reducing Sedentary Time in Patients With Cardiovascular Disease N/A